Children's Chemical Risk Reduction Act of 2007

H.R. 493, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. H.R. 1443, to treat arbitration clauses which are unilaterally imposed on consumers as an unfair and deceptive trade practice . H.R. 1685, to protect information relating to consumers, to require notice of security breaches, and for other purposes. H.R. 2099, to authorize the secretary of HHS to order a mandatory recall of any product that is regulated by the FDA. H.R. 2124, to strengthen requirements related to security breaches of data involving the disclosure of sensitive personal information. HR 2718, DSHEA Full Implementation and Enforcement Act of 2007. H.R. 3100, to amend the Federal Food, Drug, and Cosmetic Act and the Consumer Product Safety Act to increase the safety of food, toothpaste, and toys. H.R. 3588, to amend the Consumer Product Safety Act to provide the Consumer Product Safety Commission with greater authority to require recalls, mandatory routine product testing, and for other purposes. H.R. 3580, the Food and Drug Administration Amendments Act of 2007. HR 4030, To prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. H.R. 4040, Consumer Product Safety Modernization Act. H.R. 5636, to establish a comprehensive process to inform American consumers about food and product recalls, and for other purposes; to Energy & Commerce. H.R. 5769, to direct the Federal Trade Commission to revise the Telemarketing Sales Rule to explicitly prohibit the sending of a text message containing an unsolicited advertisement to a cellular telephone number listed on the national do-not-call registry; to Energy & Commerce. S. 358, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. S. 1082, the Food and Drug Administration Revitalization Act. S. 1178, to strengthen data protection and safeguards, require data breach notification, and further prevent identity theft. S. 1260, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 2256, to establish an office of international and domestic product safety and a product safety coordinating council to improve the management, coordination, promotion, and oversight of product safety responsibilities, develop a centralized public database for product recalls, advisories, and alerts, and for other purposes. S. 2275, to prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates, and for other purposes. S. 2663, to reform the Consumer Product Safety Commission to provide greater protection for children's products, to improve the screening of noncompliant consumer products, to improve the effectiveness of consumer product recall programs, and for other purposes; read the first time. S. 2794, to protect older Americans from misleading and fraudulent marketing practices, with the goal of increasing retirement security; to Judiciary. S. 3086, to amend the antitrust laws to ensure competitive market-based fees and terms for merchants' access to electronic payment systems. S. 3425, to make effective the proposed rule of the Food and Drug Administration relating to sunscreen drug products, and for other purposes. S. 3475, to amend the Federal Food, Drug, and Cosmetic Act to require manufacturers of bottled water to submit annual reports, and for other purposes. S. 3633, to amend the Federal Food, Drug, and Cosmetic Act to require country of origin labeling on prescription and over-the-counter drugs. S. 2914, to ensure the safety of seafood and seafood products being imported into the United States. S. 3108, to require the president to call a White House conference on food and nutrition. S. 3385, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply. S. 3422, to amend the Federal Food, Drug, and Cosmetic Act to provide for the establishment of a traceability system for food, and for other purposes. S. 3575, to amend the Federal Food, Drug, and Cosmetic Act with respect to nutrition labeling of food offered for sale in food service establishments. H.R. 5827, to amend the Federal Food, Drug, and Cosmetic Act to improve food safety. H.R. 5839, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs. H.R. 5904, to amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements to improve the safety of food, whether produced and distributed domestically or imported into the United States, by providing for improved information technology to identify high-risk imports and for enhanced capacity in the United States and in foreign governments to identify and address food safety issues on a scientific basis, and for other purposes. H.R. 6127, to require the president to call a White House conference on food and nutrition. H.R. 6270, to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes. H.R. 7120, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution and citation of scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 7143, to establish the Food Safety Administration within the Department of Health and Human Services to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination, and for other purposes.

Client expense: $110,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)

H.R. 3643/S. 2082 - The Coordinated Environmental Public Health Network Act of 2007 This bill would create a coordinated national health tracking program to examine the links between Americans' health and their exposure to environmental contaminants. The Breast Cancer Fund is interested because this would help identify the environmental causes of breast cancer. S. 2275 and H.R. 4030 The Children's Chemical Risk Reduction Act These bills would prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. Phthalates are known to be linked with breast cancer development, so the Breast Cancer Fund is interested in eliminating them from consumer products. S. 2045 and H.R. 4040 The Consumer Product Safety Commission Reform Act These bills would broadly reform and modernize the Consumer Product Safety Commission. The Breast Cancer fund has lobbied in support of a Feinstein amendment, which inserts phthalates as a banned substance in the manufacture of childrens toys. Consumer Product Safety Commission Met with Commissioner Moore and Commission staff to discuss implementation of S. 2045/H.R. 4040 the Consumer Product Safety Commission Reform Act. House Labor, HHS Appropriations bill for Biomonitoring and Health Tracking for Fiscal year 2009. HR 6228, the Ban Poisonous Additives Act (no Senate version) This bill would ban the chemical bisphenol-A from all food and beverage containers. The Breast Cancer Fund supports this legislation because bisphenal-A has been linked to increased rates of cancer, as well as other significant health problems. HR 5809, the Environmental Hormone Disruption Act (no Senate version) This bill would authorize the director of the National Institute of Environmental Health Sciences (NIEHS) to establish a comprehensive program to better understand the impact of hormone disrupting pollutants in the environment on the health of women and children. The Breast Cancer Fund supports this legislation because of the need for more research on the links between environmental hazards and health. Food and Drug Administration Provide public comment encouraging the FDA to restrict the use of bisphenol A (BPA) in food packaging. H.R.962 Preservation of Antibiotics for Medical Treatment Act Sponsor: Rep Slaughter, Louise McIntosh Title: To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. H.R.6432 Animal Drug User Fee Sponsor: Rep Pallone, Frank, Jr. Title: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, and for other purposes. H.R.6100 Kid-Safe Chemicals Act Sponsor: Rep Solis, Hilda L. Title: To amend the Toxic Substances Control Act to reduce the exposure of children, workers, and consumers to toxic chemical substances. S.3040 Kid-Safe Chemicals Act Sponsor: Sen Lautenberg, Frank R. Title: A bill to amend the Toxic Substances Control Act to reduce the exposure of children, workers, and consumers to toxic chemical substances. H.R.398 Healthy Places Act Sponsor: Rep Solis, Hilda L. Title: To require Federal agencies to support health impact assessments and take other actions to improve health and the environmental quality of communities, and for other purposes. H.R.1103 Environmental Justice Act Sponsor: Rep Solis, Hilda L. Title: To codify Executive Order 12898, relating to environmental justice, to require the Administrator of the Environmental Protection Agency to fully implement the recommendations of the Inspector General of the Agency and the Comptroller General of the United States, and for other purposes.

H.R. 3643/S. 2082 - The Coordinated Environmental Public Health Network Act of 2007 This bill would create a coordinated national health tracking program to examine the links between Americans' health and their exposure to environmental contaminants. The Breast Cancer Fund is interested because this would help identify the environmental causes of breast cancer. S. 2275 and H.R. 4030 The Children's Chemical Risk Reduction Act These bills would prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. Phthalates are known to be linked with breast cancer development, so the Breast Cancer Fund is interested in eliminating them from consumer products. S. 2045 and H.R. 4040 The Consumer Product Safety Commission Reform Act These bills would broadly reform and modernize the Consumer Product Safety Commission. The Breast Cancer fund has lobbied in support of a Feinstein amendment, which inserts phthalates as a banned substance in the manufacture of childrens toys. House Labor, HHS Appropriations bill for Biomonitoring and Health Tracking for Fiscal year 2009. HR 6228, the Ban Poisonous Additives Act (no Senate version) This bill would ban the chemical bisphenol-A from all food and beverage containers. The Breast Cancer Fund supports this legislation because bisphenal-A has been linked to increased rates of cancer, as well as other significant health problems. HR 5809, the Environmental Hormone Disruption Act (no Senate version) This bill would authorize the director of the National Institute of Environmental Health Sciences (NIEHS) to establish a comprehensive program to better understand the impact of hormone disrupting pollutants in the environment on the health of women and children. The Breast Cancer Fund supports this legislation because of the need for more research on the links between environmental hazards and health.

HR 4040: Consumer Product Safety Improvement Act of 2008; Provisions regarding phthalates policy, Sec. 40, S 2275 and Feinstein Amendment. HR 6903: Bruce Bento Ban Asbestos and Ban Mesothelioma Act of 2008; Provisions regarding asbestos and mesothelioma. General discussions regarding product safety.

Client expense: $9,750,000 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE, White House Office

HR 4040: Consumer Product Safety Improvement Act of 2008; Provisions regarding plasticizers, S 2275 and Feinstein Amendment regarding plasticizers. HR 5244: Credit Cardholders Bill of Rights Act of 2008; Provisions regarding implications for credit business in marketing.

Client expense: $9,750,000 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE, White House Office

H.R. 1534, Mercury Export Ban Act of 2007 H.R. 3013, Attorney-Client Privilege Protection Act of 2007 H.R. 4040, Consumer Product Safety Modernization Act H.R. 6100, Kid-Safe Chemicals Act of 2008 H.R. 6228, Ban Poisonous Additives Act of 2008 S. 742, Ban Asbestos in America Act of 2007 S. 906, Mercury Market Minimization Act of 2007 S. 2045, CPSC Reform Act of 2007 S. 2275, Children's Chemical Risk Reduction Act of 2007 S. 2928, BPA-Free Kids Act of 2008 S. 3040, Kid-Safe Chemicals Act of 2008 S. 3217, Attorney-Client Privilege Protection Act of 2008 Biomonitoring Children's Health Disinfection (Water) Endocrine Issues FY 2009 Interior, EPA and Related Agencies Appropriations (Chemical Testing and Research) FY 2009 Labor, HHS, Education Appropriations (Chemical Testing and Research) Ratification of the Stockholm/Rotterdam Conventions Toxic Substances Control Act

Client expense: $940,000 · Firm income: Not reported

H.R. 493, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. H.R. 1443, to treat arbitration clauses which are unilaterally imposed on consumers as an unfair and deceptive trade practice . H.R. 1685, to protect information relating to consumers, to require notice of security breaches, and for other purposes. H.R. 2099, to authorize the secretary of HHS to order a mandatory recall of any product that is regulated by the FDA. H.R. 2124, to strengthen requirements related to security breaches of data involving the disclosure of sensitive personal information. HR 2718, DSHEA Full Implementation and Enforcement Act of 2007. H.R. 3100, to amend the Federal Food, Drug, and Cosmetic Act and the Consumer Product Safety Act to increase the safety of food, toothpaste, and toys. H.R. 3588, to amend the Consumer Product Safety Act to provide the Consumer Product Safety Commission with greater authority to require recalls, mandatory routine product testing, and for other purposes. H.R. 3580, the Food and Drug Administration Amendments Act of 2007. HR 4030, To prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. H.R. 4040, Consumer Product Safety Modernization Act. H.R. 5636, to establish a comprehensive process to inform American consumers about food and product recalls, and for other purposes; to Energy & Commerce. H.R. 5769, to direct the Federal Trade Commission to revise the Telemarketing Sales Rule to explicitly prohibit the sending of a text message containing an unsolicited advertisement to a cellular telephone number listed on the national do-not-call registry; to Energy & Commerce. S. 358, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. S. 1082, the Food and Drug Administration Revitalization Act. S. 1178, to strengthen data protection and safeguards, require data breach notification, and further prevent identity theft. S. 1260, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 2256, to establish an office of international and domestic product safety and a product safety coordinating council to improve the management, coordination, promotion, and oversight of product safety responsibilities, develop a centralized public database for product recalls, advisories, and alerts, and for other purposes. S. 2275, to prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates, and for other purposes. S. 2663, to reform the Consumer Product Safety Commission to provide greater protection for children's products, to improve the screening of noncompliant consumer products, to improve the effectiveness of consumer product recall programs, and for other purposes; read the first time. S. 2794, to protect older Americans from misleading and fraudulent marketing practices, with the goal of increasing retirement security; to Judiciary. S. 3086, to amend the antitrust laws to ensure competitive market-based fees and terms for merchants' access to electronic payment systems.

H.R. 3643/S. 2082 - The Coordinated Environmental Public Health Network Act of 2007 This bill would create a coordinated national health tracking program to examine the links between Americans' health and their exposure to environmental contaminants. The Breast Cancer Fund is interested because this would help identify the environmental causes of breast cancer. S. 2275 and H.R. 4030 The Children's Chemical Risk Reduction Act These bills would prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. Phthalates are known to be linked with breast cancer development, so the Breast Cancer Fund is interested in eliminating them from consumer products. S. 2045 and H.R. 4040 The Consumer Product Safety Commission Reform Act These bills would broadly reform and modernize the Consumer Product Safety Commission. The Breast Cancer fund has lobbied in support of a Feinstein amendment, which inserts phthalates as a banned substance in the manufacture of childrens toys. House Labor, HHS Appropriations bill for Biomonitoring and Health Tracking for Fiscal year 2009.

Client expense: Not reported · Firm income: $30,000

HR 3903: Kids Toy Safety Act; Provisions regarding chemical regulatory policy and plasticizers. HR 4040: Consumer Product Safety Modernization Act; Provisions regarding plasticizers and Sec. 40; General discussions regarding chemical regulatory policy. S 2045: Consumer Products Safety Commission (CPSC) Reform Act; Provisions regarding plasticizers; Feinstein Amendment. S 2275: Childrens Chemical Risk Reduction Act of 2007; Feinstein Amendment and provisions regarding plasticizers. S 2663: CPSC Reform Act; Provisions regarding plasticizers; Feinstein Amendment. General discussion regarding chemical regulatory policy.

Client expense: $5,080,000 · Firm income: Not reported

CPSC reform, toy safety - S 2045, CPSC Reform Act of 2007; HR 4040, Consumer Product Safety Modernization Act. Bisphenol A, pthalates - S 2928, BPA-Free Kids Act of 2008; HR 6228, Ban Poisonous Additives Act of 2008; HR 4030, Children's Chemical Risk Reduction Act; S 2275, Children's Chemical Risk Reduction Act of 2007; HR 4040, Consumer Product Safety Modernization Act

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 1055, Toxic Right-to-Know Protection Act H.R. 1534, Mercury Export Ban Act of 2007 H.R. 3013, Attorney-Client Privilege Protection Act of 2007 H.R. 3285, Ban Asbestos in America Act of 2007 H.R. 3339, Bruce Vento Ban Asbestos and Prevent Mesothelioma Act of 2007 H.R. 4030, Children's Chemical Risk Reduction Act H.R. 4040, Consumer Product Safety Modernization Act H.R. 6100, Kid-Safe Chemicals Act of 2008 H.R. 6228, Ban Poisonous Additives Act of 2008 S. 186, Attorney-Client Privilege Protection Act of 2007 S. 595, Toxic Right-to-Know Protection Act S. 742, Ban Asbestos in America Act of 2007 S. 906, Mercury Market Minimization Act of 2007 S. 2045, CPSC Reform Act of 2007 S. 2275, Children's Chemical Risk Reduction Act of 2007 S. 2928, BPA-Free Kids Act of 2008 S. 3040, Kid-Safe Chemicals Act of 2008 S. 3217, Attorney-Client Privilege Protection Act of 2008 Biomonitoring Children's Health Disinfection (Water) Endocrine Issues FY 2009 Interior, EPA and Related Agencies Appropriations (Chemical Testing and Research) FY 2009 Labor, HHS, Education Appropriations (Chemical Testing and Research) Ratification of the Stockholm/Rotterdam Conventions Toxic Substances Control Act

Client expense: $1,440,000 · Firm income: Not reported

H.R. 493, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. H.R. 1443, to treat arbitration clauses which are unilaterally imposed on consumers as an unfair and deceptive trade practice . H.R. 1685, to protect information relating to consumers, to require notice of security breaches, and for other purposes. H.R. 2099, to authorize the secretary of HHS to order a mandatory recall of any product that is regulated by the FDA. H.R. 2124, to strengthen requirements related to security breaches of data involving the disclosure of sensitive personal information. HR 2718, DSHEA Full Implementation and Enforcement Act of 2007. H.R. 3100, to amend the Federal Food, Drug, and Cosmetic Act and the Consumer Product Safety Act to increase the safety of food, toothpaste, and toys. H.R. 3588, to amend the Consumer Product Safety Act to provide the Consumer Product Safety Commission with greater authority to require recalls, mandatory routine product testing, and for other purposes. H.R. 3580, the Food and Drug Administration Amendments Act of 2007. HR 4030, To prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. H.R. 4040, Consumer Product Safety Modernization Act. H.R. 5636, to establish a comprehensive process to inform American consumers about food and product recalls, and for other purposes; to Energy & Commerce. S. 358, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. S. 1082, the Food and Drug Administration Revitalization Act. S. 1178, to strengthen data protection and safeguards, require data breach notification, and further prevent identity theft. S. 1260, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 2256, to establish an office of international and domestic product safety and a product safety coordinating council to improve the management, coordination, promotion, and oversight of product safety responsibilities, develop a centralized public database for product recalls, advisories, and alerts, and for other purposes. S. 2275, to prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates, and for other purposes. S. 2663, to reform the Consumer Product Safety Commission to provide greater protection for children's products, to improve the screening of noncompliant consumer products, to improve the effectiveness of consumer product recall programs, and for other purposes; read the first time.

S.2275; The Feinstein Amendment (to S.2663; The Consumer Product Safety Commission Reform Act); lobbied against the portion of the bill to ban phthalates in favor of alternative plasticizers that have weaker safety records.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 3643/S. 2082 - The Coordinated Environmental Public Health Network Act of 2007 This bill would create a coordinated national health tracking program to examine the links between Americans' health and their exposure to environmental contaminants. The Breast Cancer Fund is interested because this would help identify the environmental causes of breast cancer. S. 2275 and H.R. 4030 The Children's Chemical Risk Reduction Act These bills would prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. Phthalates are known to be linked with breast cancer development, so the Breast Cancer Fund is interested in eliminating them from consumer products. S. 2045 and H.R. 4040 The Consumer Product Safety Commission Reform Act These bills would broadly reform and modernize the Consumer Product Safety Commission. The Breast Cancer fund has lobbied in support of a Feinstein amendment, which inserts phthalates as a banned substance in the manufacture of childrens toys.

Client expense: Not reported · Firm income: $30,000

HR 2638: Department of Homeland Security Appropriations Act of 2008; Provisions relating to mandated technologies. HR 4040: Consumer Product Safety Modernization Act; Provisions relating to naphthalene. S 2045: CPSC Reform Act; Provisions relating to banning phthalates. S 2275: Childrens Chemical Risk Reduction Act of 2007; Feinstein Amendment and provisions relating to banning phthalates. S 2663: CPSC Reform Act; Provisions relating to banning phthalates and provisions relating to naphthalene.

Client expense: $3,050,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 1055, Toxic Right-to-Know Protection Act H.R. 1534, Mercury Export Ban Act of 2007 H.R. 3013, Attorney-Client Privilege Protection Act of 2007 H.R. 3285, Ban Asbestos in America Act of 2007 H.R. 3339, Bruce Vento Ban Asbestos and Prevent Mesothelioma Act of 2007 H.R. 4030, Children's Chemical Risk Reduction Act H.R. 4040, Consumer Product Safety Modernization Act S. 186, Attorney-Client Privilege Protection Act of 2007 S.595, Toxic Right-to-Know Protection Act S. 742, Ban Asbestos in America Act of 2007 S. 906, Mercury Market Minimization Act of 2007 S. 2045, CPSC Reform Act of 2007 S. 2275, Children's Chemical Risk Reduction Act of 2007 Biomonitoring Children's Health Disinfection (Water) Endocrine Issues Ratification of the Stockholm/Rotterdam Conventions Toxic Substances Control Act

Client expense: $770,000 · Firm income: Not reported

Toy safety, Consumer Products Safety Commission reform, interagency working group on import safety - HR 3691, SAFE Consumer Product Act; HR 3743, To declare certain children's products containing lead to be banned hazardous substances; HR 4040, Consumer Product Safety Modernization Act; S 2045, CPSC Reform Act of 2007; S 2663, CPSC Reform Act. Phthalates in children's products - HR 4030, Children's Chemical Risk Reduction Act; HR 4040, Consumer Product Safety Modernization Act; S 2275, Children's Chemical Risk Reduction Act of 2007; S 2663, CPSC Reform Act.

Client expense: Not reported · Firm income: $100,000

Phthalates S 2275

Client expense: $10,500,000 · Firm income: Not reported

H.R. 3339, Bruce Vento Ban Asbestos and Prevent Mesothelioma Act of 2007 H.R. 4030, Children's Chemical Risk Reduction Act H.R. 4040, Consumer Product Safety Modernization Act S. 186, Attorney-Client Privilege Protection Act of 2007 S. 595, Toxic Right-to-Know Protection Act S. 742, Ban Asbestos in America Act of 2007 S. 906, Mercury Market Minimization Act of 2007 S. 2045, CPSC Reform Act of 2007 S. 2275, Children's Chemical Risk Reduction Act of 2007 Biomonitoring Children's Health Disinfection (Water) Endocrine Issues Ratification of the Stockholm/Rotterdam Conventions Toxic Substances Control Act H.R. 1055, Toxic Right-to-Know Protection Act H.R. 1534, Mercury Export Ban Act of 2007 H.R. 3013, Attorney-Client Privilege Protection Act of 2007 H.R. 3285, Ban Asbestos in America Act of 2007

Client expense: $1,270,000 · Firm income: Not reported